Literature DB >> 8398691

Functional and histological bladder damage in mice after photodynamic therapy: the influence of sensitiser dose and time of administration.

F A Stewart1, Y Oussoren.   

Abstract

The bladders of anaesthetised mice were illuminated with red laser light (630 nm) at intervals of 1 day to 4 weeks after i.p. administration of Photofrin. Light was delivered intravesically by inserting a fibre optic, with a diffusing bulb tip, into the centre of fluid filled bladders. A single light dose of 11.3 J cm-2 applies 1 day after 10 mg kg-1 Photofrin caused a severe acute response, with increased urination frequency (five to seven times control) and hematuria. Recovery was good, however, and by 10 weeks only a mild (approximately two-fold) increase in frequency remained. There was no reduction in the amount of acute bladder damage or in the rate of healing when the interval between Photofrin and light was increased from 1 to 7 days but a 2 to 3 week interval lead to a significant reduction in damage. For an interval of 4 weeks there was only a mild (less than two-fold) increase in urination frequency during the first week. A drug dose of 2.5 mg kg-1 given 1 day before illumination caused transient haematuria but no increase in urination frequency. Doses of 5, 7.5 or 10 mg kg-1 all caused photosensitisation and the amount of bladder damage was drug dose dependent. The bladder seems to be well able to recover from severe acute damage induced by PDT. Occasional incidences of pyelonephritis were seen, however, suggesting that urinary tract infection during the acute period may lead to permanent renal damage.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8398691      PMCID: PMC1968612          DOI: 10.1038/bjc.1993.407

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  Light dosimetry for photodynamic therapy by whole bladder wall irradiation.

Authors:  W M Star; H P Marijnissen; H Jansen; M Keijzer; M J van Gemert
Journal:  Photochem Photobiol       Date:  1987-11       Impact factor: 3.421

2.  Clinical laser photodynamic therapy in the treatment of bladder carcinoma.

Authors:  B P Shumaker; F W Hetzel
Journal:  Photochem Photobiol       Date:  1987-11       Impact factor: 3.421

3.  Hematoporphyrin photodynamic therapy for transitional cell carcinoma of the bladder--an update.

Authors:  R C Benson
Journal:  Adv Exp Med Biol       Date:  1985       Impact factor: 2.622

4.  Bladder damage in mice after combined treatment with cyclophosphamide and X-rays. The influence of timing and sequence.

Authors:  G Edrees; A Luts; F Stewart
Journal:  Radiother Oncol       Date:  1988-04       Impact factor: 6.280

5.  Photodynamic therapy in the management of resistant lower urinary tract carcinoma.

Authors:  U O Nseyo; T J Dougherty; L Sullivan
Journal:  Cancer       Date:  1987-12-15       Impact factor: 6.860

6.  Photoradiation therapy of bladder tumors.

Authors:  H Hisazumi; T Misaki; N Miyoshi
Journal:  J Urol       Date:  1983-10       Impact factor: 7.450

7.  Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder.

Authors:  G R Prout; C W Lin; R Benson; U O Nseyo; J J Daly; P P Griffin; J Kinsey; M E Tian; Y H Lao; Y Z Mian
Journal:  N Engl J Med       Date:  1987-11-12       Impact factor: 91.245

8.  Complications of whole bladder dihematoporphyrin ether photodynamic therapy.

Authors:  J I Harty; M Amin; T J Wieman; M T Tseng; D Ackerman; W Broghamer
Journal:  J Urol       Date:  1989-06       Impact factor: 7.450

9.  Distribution and elimination of Photofrin II in mice.

Authors:  D A Bellnier; Y K Ho; R K Pandey; J R Missert; T J Dougherty
Journal:  Photochem Photobiol       Date:  1989-08       Impact factor: 3.421

10.  Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Phase I study.

Authors:  W F Sindelar; T F DeLaney; Z Tochner; G F Thomas; L J Dachoswki; P D Smith; W S Friauf; J W Cole; E Glatstein
Journal:  Arch Surg       Date:  1991-03
View more
  1 in total

1.  Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts.

Authors:  H B Ris; T Krueger; A Giger; C K Lim; J C Stewart; U Althaus; H J Altermatt
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.